Worldwide initiatives to eliminate cervical cancer
- PMID: 34669201
- PMCID: PMC9298014
- DOI: 10.1002/ijgo.13879
Worldwide initiatives to eliminate cervical cancer
Abstract
In 2020, more than 600 000 women were diagnosed with cervical cancer and 342 000 women died worldwide. Without comprehensive control, rates of cervical cancer incidence and mortality are expected to worsen. In 2020, the World Health Organization adopted the global strategy to eliminate cervical cancer to the threshold of four cases per 100 000 women within the 21st century, using a triple pillar intervention strategy comprising 90% of girls fully vaccinated by the age of 15 years, 70% of women screened by the age of 35 years and again by 45 years, and 90% of women with precancer treated and 90% of women with invasive cancer managed. In countries with high cervical cancer incidence, a tremendous effort will be needed to overcome the challenges. This article discusses the efforts in place to accelerate achievement of this ambitious goal.
Keywords: FIGO Cancer Report; cervical cancer; elimination initiatives; prevention; screening; treatment.
International Journal of Gynecology & Obstetrics© 2021 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.
Conflict of interest statement
The authors have no conflicts of interest.
References
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209‐249. - PubMed
-
- Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. IARC; 2018.
-
- Shankar A, Roy S, Rath G, Kamal VK, Kharade V, Sandeep K. Carcinoma uterine cervix: evolving trends and Impact of national cancer control Program in India. Ind J Soc Prev Rehab Onc. 2017;1:16‐22.
-
- Serrano B, de Sanjosé S, Tous S, et al. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer. 2015;51:1732‐1741. - PubMed
